Schedule 13G ownership disclosure

PMV PHARMACEUTICALS INC

Security class unavailable · CUSIP: 69353Y103

Event date: 2021-10-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-300999
Form type
SC 13G/A
Filer
Euclidean Capital LLC
CIK
CIK 1825034
Filed
Oct 18, 2021
Reporting period
Oct 15, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub